 NEW YORK, May 18, 2022 GLOBE NEWSWIRE -- Indaptus Therapeutics, Inc. Nasdaq: INDP Indaptus or the Company today announced that Jeffrey A. Meckler, Chief Executive Officer of Indaptus, will present a corporate overview at the H.C. Wainwright Global Investment Conference on Wednesday, May 25, 2022 at 8:30am ET. 